Androgen Replacement Therapy Market

 decision foresight.png

Global Androgen Replacement Therapy  Market Size, Share, Growth, Industry Trends and Forecast 2020-2030




Global Androgen Replacement Therapy Market held USD 1736.9 million in 2020 and is to grow with a CAGR of 3.5% from 2020-2030. Androgen replacement therapy is commonly referred to as hormone replacement therapy. The results of decrease development in gonads are counteracted. Hypogonadism in men is a clinical syndrome that results in the tests failing to produce physiological testosterone levels. The primary explanation for the hypogonadism can be a test issue. The secondary reason is a problem with the primary and secondary hypothalamus or pituitary gland, or both. Main hypogonadism is caused by genetic anomalies, testicular damage, orchitis, radiation therapy or chemotherapy.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020365

Market Dynamics and Factors : 

Hypogonadism is more common in older men, men with obesity, men with co-morbidity and men with poor state of health. In addition, according to the Urology Journal's Therapeutic Advances: 2016 testosterone was one of the most widely prescribed drugs in the U.S.U.S. proposed stringent regulations Food and Drug Administration (FDA) is expected to hamper androgen replacement therapy market growth for androgen replacement therapy in the near future with the application of testosterone products because of increased risk of adverse cardiovascular events. The United States in February 2018 FDA revised its policy that testosterone replacement drug manufacturers need to change the labelling to warn patients of potential side effects, for which the risk of heart attack and stroke is increased. The growing prevalence of hypogonadism in adult men around the world is expected to fuel growth in the demand for androgen-replacement therapy market size. According to the European Urology Association: 2016 study, the prevalence of hypogonadism among middle-aged people ranges from 2.1 per cent to 12.8 per cent which will spur androgen replacement therapy market share.

Market Segmentation:

  • Global Androgen Replacement Therapy Market – By Product

    • Creams

    • Patches

    • Injections

    • Implants

    • Orals

    • Others

  • Global Androgen Replacement Therapy Market – By Ingredient

    • Testosterone

    • Methyl Testosterone

    • Testosterone Undecanoate

    • Testosterone Enanthate

    • Others

  • Global Androgen Replacement Therapy Market – By Distribution Channel

    • Hospitals

    • Pharmacies

    • Retail

    • Online

  • Global Androgen Replacement Therapy Market – By Geography

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • U.K.

      • France

      • Germany

      • Italy

      • Rest of Europe

    • Asia-Pacific

      • Japan

      • China

      • India

      • Australia

      • Rest of Asia Pacific

    • ROW

      • Latin America

      • Middle East

      • Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020365

Geographic Analysis : 

In Europe, the prevalence of low testosterone and hypogonadic symptoms in men between 40 and 79 years of age ranges from 2.1% to 5.7% is anticipated to drive size for androgen replacement therapy market. In addition, major companies on the market are focused on acquiring licensing agreements to acquire commercial rights for a particular country which is expected to drive growth in the Asia Pacific androgen replacement therapy market. Acerus Pharmaceuticals Corporation, for example, announced in December 2016 that it was signing an agreement giving Hyundai Pharm Co exclusive right to sell NATESTO in South Korea. Ltd., a pharmaceutical business based in South Korea.

Competitive Scenario : 

Global androgen replacement therapy market, is witnessing cut throat market competition owing to presence of large-scale players. Key companies are also expanding their manufacturing facilities to cater to androgen replacement therapy demand. Key players enhancing the global androgen replacement therapy market size include Ferring Holding SA, Acerus Pharmaceuticals Corporation, Eli Lilly and Company, Upsher-Smith Laboratories, LLC, AbbVie, Inc., Bayer AG, Allergan Plc., Kyowa Kirin International Plc., Mylan N.V., Endo Pharmaceuticals, Inc., Pfizer, Inc., Clarus Therapeutics, Novartis International AG,Perrigo Company Plc.

Connect to Anakyst @ https://www.decisionforesight.com/speak-analyst/DFS020365

How will this Market Intelligence Report Benefit You?

  1. The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

  2. Exclusive insight into the key trends affecting the Global Androgen Replacement Therapy  industry, although key threats, opportunities and disruptive technologies that could shape the Global Androgen Replacement Therapy  Market supply and demand.

  3. The report tracks the leading market players that will shape and impact the Global Androgen Replacement Therapy  Market most.

  4. The data analysis present in the Global Androgen Replacement Therapy  Market report is based on the combination of both primary and secondary resources.

  5. The report helps you to understand the real effects of key market drivers or retainers on Global Androgen Replacement Therapy  Market business.

The 2021 Annual Global Androgen Replacement Therapy  Market offers:

  • 100+ charts exploring and analysing the Global Androgen Replacement Therapy  Market from critical angles including retail forecasts, consumer demand, production and more

  • 15+ profiles of top producing states, with highlights of market conditions and retail trends

  • Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

  • Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Androgen Replacement Therapy  Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020365

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: sales@decisionforesight.com

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionForesi1

https://www.linkedin.com/company/decision-foresight/


Comments

Popular posts from this blog

Automotive Trailer

Automotive Lubricants

Lyocell Fiber